Augmentin can treat a UTI, but it’s not the best choice. Compared to first-line antibiotics, Augmentin (amoxicillin-clavulanate) has significantly lower cure rates for bladder infections, and most clinical guidelines position it as a backup option rather than a go-to treatment. If your doctor prescribed it for you, there’s likely a specific reason, but it’s worth understanding how it stacks up.
How Augmentin Works Against UTI Bacteria
Augmentin combines two ingredients: amoxicillin, which kills bacteria by breaking apart their cell walls, and clavulanate, which blocks a defense mechanism bacteria use to survive. Many UTI-causing bacteria, especially E. coli (responsible for roughly 80% of bladder infections), produce enzymes that can deactivate amoxicillin on its own. Clavulanate disables those enzymes, giving amoxicillin a chance to work.
This combination sounds like it should be highly effective, but in practice, the results for UTIs are underwhelming compared to other antibiotics. The reason has to do with how the drug moves through your body and where it concentrates.
Cure Rates Compared to Other Antibiotics
A randomized trial published in JAMA compared a three-day course of Augmentin to ciprofloxacin in women with uncomplicated bladder infections. The results were notably lopsided: 58% of women on Augmentin were clinically cured, compared to 77% on ciprofloxacin. When researchers checked for bacteria in the urine two weeks later, 76% of the Augmentin group had cleared the infection versus 95% of the ciprofloxacin group.
What made this finding especially striking was that Augmentin underperformed even when the bacteria were confirmed to be susceptible to it. Among women whose E. coli strains should have responded to Augmentin, only 60% were cured, compared to 77% with ciprofloxacin. The likely explanation: Augmentin doesn’t do a good job clearing E. coli from the vaginal area, where the bacteria can linger and quickly reinfect the bladder. At the two-week follow-up, 45% of women in the Augmentin group still had E. coli colonizing the vagina, compared to just 10% in the ciprofloxacin group.
A large network meta-analysis looking across multiple studies reached a blunt conclusion: among commonly used UTI antibiotics, Augmentin was the only one that was significantly less effective than the rest. Nitrofurantoin, trimethoprim-sulfamethoxazole, and fluoroquinolones all performed similarly to each other, with Augmentin trailing behind.
Where It Falls in Treatment Guidelines
Major infectious disease guidelines do not recommend Augmentin as a first-line treatment for uncomplicated UTIs. The preferred options for a straightforward bladder infection are nitrofurantoin, trimethoprim-sulfamethoxazole, and fosfomycin. These drugs concentrate heavily in the urinary tract, which makes them especially effective at clearing infections there.
The Infectious Diseases Society of America notes that Augmentin “may be appropriate in select settings or situations” but groups it with agents that are “less well studied” for UTI treatment. In practice, this means a doctor might prescribe it when urine culture results show the bacteria are resistant to first-line drugs, when a patient has allergies to preferred antibiotics, or during pregnancy when options are more limited.
When Augmentin Might Still Be Prescribed
There are situations where Augmentin makes sense despite its lower overall cure rates. Pregnant women have fewer safe antibiotic choices, and Augmentin is classified as relatively low-risk in pregnancy based on animal studies showing no fetal harm. It’s sometimes chosen when the bacteria causing the infection are resistant to nitrofurantoin or trimethoprim-sulfamethoxazole, which is increasingly common in some regions.
For kidney infections (pyelonephritis), Augmentin sits firmly in second-line territory. Johns Hopkins guidelines note that oral beta-lactam antibiotics like Augmentin have historically been associated with higher relapse rates for kidney infections, even when the bacteria test susceptible. It may be used for certain less common UTI-causing bacteria, but fluoroquinolones remain the standard outpatient treatment for kidney infections where local resistance rates allow.
Side Effects to Expect
Augmentin is rougher on the digestive system than most UTI antibiotics. Diarrhea or loose stools affect about 9% of people on standard tablets and nearly 15% on extended-release versions. Nausea occurs in about 3% of users, and vomiting in about 1%. The diarrhea tends to be dose-dependent, so higher doses mean more gut trouble.
Yeast infections are another common side effect, reported in 1% to 3.3% of women depending on the formulation. This happens because the antibiotic disrupts the normal balance of bacteria throughout the body, not just in the urinary tract. Symptoms include vaginal itching and a thick, white discharge.
In rare cases, Augmentin can trigger a severe form of diarrhea caused by C. difficile bacteria overgrowth in the colon. If you develop watery, persistent, or bloody diarrhea during or after finishing a course, that warrants prompt medical attention.
Why Your Doctor May Have Chosen It Anyway
Antibiotic prescribing for UTIs isn’t one-size-fits-all. Your doctor may have culture results showing your specific bacteria respond well to Augmentin, or you may have allergies or other conditions that rule out the usual first-line drugs. Resistance patterns also vary by region. In some areas, E. coli resistance to trimethoprim-sulfamethoxazole exceeds 20%, which can push Augmentin up the list of practical alternatives.
If you’ve been prescribed Augmentin for a UTI, finishing the full course gives you the best chance of clearing the infection. If your symptoms haven’t improved within two to three days, contact your provider. A persistent infection may need a different antibiotic or further testing to identify what’s going on.